A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

Published:2008-07-10 Issue:9 Volume:15 Page:809-815
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Homma Yukio,Yamaguchi Takuhiro,Yamaguchi Osamu

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2008.02104.x/fullpdf

Reference18 articles.

1. Overactive bladder significantly affects quality of life;Abrams;Am. J. Manag. Care,2000

2. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine;Kobelt;BJU Int,1999

3. Prevalence and burden of overactive bladder in the United States;Stewart;World J. Urol,2003

4. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int,2001

5. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review;BMC Women's Health;2024-05-16

2. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis;International braz j urol;2023-10

3. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

4. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

5. Comparative Assessment of Efficacy and Safety of approved Oral Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis;2023-02-07